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Summary 
Background - Ischemic stroke is often treated with thrombolysis in the acute phase, 
irrespective of the cause. It remains unclear whether thrombolysis is safe in patients with 
cervical artery dissection (CAD). The aim of the current meta-analysis is to pool all available 
series and individual patient data and to provide a valid estimate of safety and outcome of 
thrombolytic therapy in patients with CAD-related stroke.  
Methods - We performed a systemic literature search on thrombolytic treatment (intravenous 
thrombolysis only (IVT), intra-arterial thrombolysis only (IAT), or combined procedures) in 
patients with CAD-related stroke. Individual patient data (IPD) were collected from 
manuscripts or by contacting the authors. Pooled symptomatic intracerebral hemorrhage 
(SICH) and mortality rates, only corrected for heterogeneity were calculated. In a multivariate 
regression model, with functional outcome on the modified Rankin Scale (mRS) as the 
dependent variable, adjustments were made for the following possible explanatory variables: 
gender, age, preceding trauma, dissected artery, onset to treatment time, stroke severity on 
the National Institutes of Health Stroke Scale score (NIHSS), and treatment (IVT, IAT or 
combined). 
Findings - Fourteen retrospective series and 22 case reports comprising 190 patients were 
identified. From 180 patients IPD were available. Patients were predominantly (68%) female 
with a median age of 46 years. Patients presented with severe stroke symptoms (median 
NIHSS score 16 points). Treatment modality was IVT in 68%, IAT in 20%, and combined in 
12%. The pooled SICH rate was 3.1% (95% CI 1.3-7.2%). Overall mortality was 8.1% (95% 
CI 4.9-13.2%). 37% (95% CI 29-49%) reached excellent outcome (mRS 0-1). Stroke severity 
on NIHSS before treatment was the only predictor for functional outcome. 
Interpretation - The results of our study suggest that thrombolysis in patients with CAD-
related stroke is safe. There is no evidence to exclude patients suspected of dissection-
related stroke from thrombolytic treatment. 
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Introduction 
 
Approximately 2% of all ischemic strokes are caused by cervical artery dissection (CAD), 
whereas in patients under 50, this number is 10-25%.1;2 CAD is characterized by the 
presence of an intramural hematoma due to an intimal tear in the carotid or vertebral artery. 
Subsequent brain ischemia is believed to be thrombo-embolic rather than hemodynamic.3  
Randomised trials investigating thrombolytic therapy in acute ischemic stroke patients did not 
exclude patients with CAD.4-10 However, safety and efficacy has never been investigated in 
this particular subgroup. Therefore, it remains unknown if thrombolytic therapy can be given 
in ischemic strokes secondary to CAD.  
The most feared complication in thrombolytic therapy in stroke is symptomatic intracranial 
hemorrhage (SICH). In the subgroup of CAD patients, who suffer from a damaged vessel 
wall, this small but non-negligible risk may potentially be higher. Besides intracerebral 
hemorrhage, other potential complications of thrombolytic therapy in this group of patients 
are pseudo-aneurysm formation and subarachnoid bleeding of an intracranially extending 
dissection. Nevertheless, several retrospective case series suggested that thrombolytic 
therapy in CAD patients is safe.11;12 The aim of the current meta-analysis is to pool all 
available series and individual patient data and to provide a valid estimate of safety and 
outcome of thrombolytic therapy in patients with CAD-related stroke. In addition, predictors of 
outcome after thrombolytic treatment in CAD-patients will be evaluated. 
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Methods   
 
Study selection 
We systematically searched the PUBMED and EMBASE database up to 2010 (week 11) for 
publications on thrombolytic treatment in patients with CAD-related ischemic stroke, using 
the following combination of variables:  [“dissection"]  AND  [“carotid” or “vertebral” or 
“cervical” or “extracranial” or "stroke" or “brain ischemia” or “brain infarction”] AND 
[“thrombolysis” or “recombinant tissue plasminogen activator” or “rtPA” or “tissue 
plasminogen activator” or “tPA” or “urokinase” or "pro-urokinase"]. Furthermore, we searched 
for relevant studies in the Cochrane Library and Cochrane Central Register of Controlled 
Trials, and hand searched citations of the retrieved studies. Finally, experts in the field were 
consulted. 
We included studies that investigated thrombolytic therapy in patients with CAD-related 
stroke, either when this was analyzed as a main analysis or as a subgroup analysis. Since 
the number of publications on this topic is scarce, no lower limit of number of patients per 
study was applied. For the same reason, we included English, German and French 
publications and publications in other languages as long as an abstract in English, German 
of French was provided. Patients with a dissection limited to the intracranial vessel(s) only, or 
an aortic dissection with extension into the cervical arteries, were excluded, because of the 
different pathogenesis involved.13 CAD could be diagnosed with combined color duplex or 
sonography, CTA, MRA, or conventional angiography. Diagnosis of a dissection could be 
confirmed before or after thrombolytic therapy. Since most of the included studies did not 
systematically assess the degree of stenosis before and after treatment, recanalization could 
not be included as a reliable variable in our analysis. We analyzed the following treatment 
categories: intravenous thrombolysis only (IVT), intra-arterial thrombolysis only (IAT), and 
combined treatment. Combination treatment was defined as IVT and/or IAT, followed by 
either mechanical thrombectomy, stent placement or other endovascular procedures. Crucial 
for the aim of the present study is that thrombolytic therapy had to be administered in the 
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acute phase of ischemic stroke, ultimately within 24 hours after symptom onset. Studies 
describing interventions started beyond 24 hours, often because of secondary worsening of a 
patient, are not in the domain of the present study. 
 
Data extraction 
The following baseline characteristics were collected: gender, age, preceding trauma 
(including minor trauma), stroke severity at presentation in terms of the National Institutes of 
Health Stroke Scale score  (NIHSS), dissected artery (carotid or vertebral artery), vessel 
occlusion before treatment, intracranial extension, time from symptom onset to treatment, 
treatment modality (IVT only, IAT only or combined) and duration of follow-up. 
 
Regarding safety, the following variables were extracted: mortality, symptomatic intracerebral 
hemorrhage (SICH) as defined by the authors, and recurrent stroke. Additional adverse 
events as reported by the authors, were collected and described. Functional outcome was 
assessed by means of the level of dependency at follow-up. Excellent outcome was defined 
as 0-1 on the modified Rankin Scale (mRS), and favourable outcome as a mRS score of 0-2.  
 
Data extraction was performed by two independent observers (SZ, PN), and disagreements 
were resolved by consensus. When mRS was unavailable, two independent observers 
reconstructed the score but only if this could clearly be deducted from the case description, 
according to the official mRS criteria.14 Adverse events were reported as defined by the 
investigators of the individual studies.  
 
Individual patient data (IPD) 
Of all case series that reported summarised data only, the authors were contacted, and we 
allowed them to provide individual patient data (IPD) of both published and unpublished 
cases. We sent them a uniform and pre-specified datasheet, allowing them to fill out IPD 
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electronically. Authors of case report were contacted  if data we needed for the analysis were 
missing in the manuscript.  
 
Statistical analyses  
All analyses were performed on level of individual patient data with pooled proportion mixed 
analyses. Pooled proportions for the primary safety endpoints SICH and death rate, and for 
excellent or favourable outcome, were calculated accounting for heterogeneity of the studies. 
Since intravenous thrombolysis is of particular interest of this meta-analysis proportions were 
also calculated for patients treated with IVT only. The following variables were included in 
two univariate models as predictors for excellent and favourable outcome respectively: 
gender, age, preceding trauma, dissected artery, onset to treatment time, stroke severity 
(NIHSS) and treatment modality. Onset to treatment time was analyzed both as continuous 
and as categorical variable (< 120 minutes, 120-180 minutes and > 180 minutes). In a 
subsequent multivariate analysis, adjustments were made for the predictors that were 
significantly (p < 0.05) associated with both excellent and favourable outcome in the 
univariate analysis.  
 
Publication bias 
A sensitivity analysis was performed with extraction of the results of the case reports, to 
evaluate the effect of possible publication bias in the latter.  
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Findings 
 
Studies 
Our search strategy yielded 186 citations. After evaluating the abstracts and, if needed, full 
texts, 150 publications were excluded. As a result, 36 publications were available for this 
meta-analysis, including 190 patients. All studies were retrospective series or single case 
reports; no randomized controlled clinical trials were identified. In total, 14 case series 
presented data of thrombolysis in dissection related stroke, including 166 patients.11;12;15-26 
Nine studies used data from stroke registers 15;19;23;26 or thrombolysis registers 11;16;21;27 and 
one was based on a non-defined hospital registry.20 Of these, 3 studies were multicenter 
studies.11;15;27 An overview of the study characteristics of the case series is presented in 
Table 1. In addition, 22 case reports were retrieved describing another 24 patients.28-49. IPD 
were (partly) available in 33 publications including 72 patients. From the remaining 3 
publications presenting aggregate data only, IPD of another 108 patients could be collected 
of which some had not been published yet. In total, individual patient data from 180 patients 
were available for this study.  
 
Baseline characteristics 
Patients of which IPD were available (n=180) were predominantly female (68%) with a mean 
age of 46 ± 11 years. Most patients (60%) presented with severe stroke symptoms (NIHSS ≥ 
15). Median onset to treatment time was 165 minutes, whereas 6% of the IVT treated 
patients was treated beyond the therapeutic window of 4.5 hours after symptom onset. All 
baseline characteristics are presented in Table 2. 
 
Safety  
The pooled mortality rate was 8.1% (95% CI 4.9%-13.2%). However, in 7 patients (4%) 
survival or death was not specified. Pooled mortality in patients treated with IVT only was 
6.7% (95% CI 3.4-12.8%).  SICH occurred in 8 of 180 patients (3.1%; 95% CI 1.3-7.2%), of 
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which 2 were fatal. In IVT only group, 4 patients experienced SICH (3.3%; 95% CI 1.2-8.5%).  
Recurrent stroke occurred in 4.5% (95% CI 2.3-8.7%) and in 6.8% (95% CI 3.4-13.0%) in 
patients treated with IVT only. 
In addition, asymptomatic ICH was reported in 26 patients (14.7%; 95% CI 9.3-19.7%). Data 
on expansion of intramural hematoma was not available in 89 patients. One (1%; 95% CI 
0.0-6.0%) patient with right vertebral artery dissection treated with IVT experienced 
hematoma expansion (IPD, unpublished data) although with good recovery (mRS 1 at 3 
months). Pseudo-aneurysm was reported in 8 of 133 patients (6.0%; 95% CI 2.6-11.5%) of 
which this information was available. One asymptomatic subarachnoid bleeding (IPD, no 
published data) but no symptomatic subarachnoid bleeding was reported. Eight of 176 
patients (4.5%; 95% CI 2.3-8.7%) had recurrent stroke. Progression of the infarct was 
reported in 13 of 161 patients (8.1%; 95% CI 4.4-13.4%) (Table 3a and 3b).  
 
Functional Outcome 
Functional outcome was available for 158 patients. In 15 cases, mRS could be deducted 
reliably from the description of the functional status. In total, 41.0% (95% CI 31.4-51.4%) 
made an excellent recovery (mRS 0-1), whereas 59.5% (95% CI 52.1-66.6%) attained 
favourable outcome (mRS 0-2) at a median follow-up duration of 3 months (range 5 days – 
18 months). 
 
Regression models 
Predictors of excellent (mRS 0-1) and of favourable (mRS 0-2) functional outcome are 
presented in Table 4. In the univariate analyses, only stroke severity (NIHSS on admission) 
was significantly associated with both excellent and favourable outcome. The odds ratio (OR) 
for excellent outcome was 0.88 (95% CI 0.82-0.93); for each point increase on NIHSS. For 
favourable outcome this OR was 0.87 (95% CI 0.82-0.92). Regarding location, vertebral 
artery dissection was significantly associated with excellent outcome compared to carotid 
artery dissection (OR 2.64, 95% CI 1.24-5.62), but not with favourable outcome. Gender, 
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age, and trauma were not associated with outcome. Onset-to-treatment-time (OTT) was 
neither associated with outcome, analyzed as either a continuous or categorical variable. In 
the multivariate model, we adjusted for stroke severity only, since NIHSS was significantly 
associated with both excellent and favourable outcome. In this model, the relation between 
location of the dissected artery (carotid or vertebral artery) and excellent outcome remained 
significant (OR 3.94, 95% CI 1.40-11.12). After adjustment for stroke severity, combined 
treatment showed a trend towards favourable outcome compared to IVT alone (OR 3.87, 
95% CI 0.93-16.06, p=0.06).  
 
Publication bias 
Leaving out the results of the case reports did not alter the main findings, suggesting that 
publication bias did not play a role in case reports compared to the results of the larger 
studies.  
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Discussion 
 
This meta-analysis on IPD presents the largest number of CAD patients treated with 
thrombolysis to date and suggests that thrombolysis in acute ischemic stroke due to CAD is 
safe.  
 
Mortality in our study is 8.1% (6.7% in IVT patients), which is comparable with previously 
published mortality rates in patients with stroke from all causes, treated with thrombolysis. In 
Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST), comprising 
the largest thrombolysis registry of 6,483 IVT treated patients with stroke from all causes, 
unadjusted mortality was 11.3%.50 Patients in our study were more than 20 years younger 
compared to the population in SITS-MOST, but had more severe symptoms (median NIHSS 
of 16, versus 12 in SITS-MOST). SICH rate in our study was 3.1% in all patients and 3.3% in 
patients treated with IVT only. Since SICH was not uniformly defined, we used a pragmatic 
instead of a fixed definition of SICH. By considering every intracerebral hematoma which was 
reported as symptomatic by the author, we have a warranted that all clinically relevant SICH 
are included in our analysis. This heterogeneous definition of SICH makes direct comparison 
with SICH rates with other studies difficult. In SITS-MOST, according to the broadest 
definition of SICH (i.e. any deterioration in NIHSS score within 7 days and intracerebral 
hemorrhage of any type in any post-treatment imaging scan after the start of thrombolytic 
treatment), the SICH rate was 7.3%.50 According to a less strict definition of SICH, i.e. clinical 
deterioration of ≥ 4 points of the NIHSS with parenchymal hematoma type II being the 
predominant cause of deterioration, this rate was 1.7%. Our rate with mixed definitions of 
ICH falls precisely in between the outer borders of SITS-MOST. Mortality and functional 
outcome rates of our study and of SITS-MOST are listed in Table 5. 
 
Favourable outcome in CAD patients in our study was 60% (61% for patients treated with 
IVT only). Despite the high stroke severity at baseline in our population, the rate of 
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favourable outcome is somewhat higher than the 55% reported in SITS-MOST. This can be 
explained by the relatively young age of our study population, with SICH and death rates that 
are comparable to those observed in SITS-MOST.  
 
In addition to analysis of the primary aims, this study allowed us to indirectly compare the 
effect of different treatment strategies in the acute phase (IVT only, IAT only or combined 
procedures) in CAD-related stroke. Studies directly comparing different treatment strategies 
are not available in literature to data. Adjusted for stroke severity, the combined treatment of 
chemical lysis and endovascular procedures showed a trend towards favourable outcome. 
This trend could not be confirmed for excellent outcome, which might be due to the low 
number of patients receiving this combination of treatments in the acute phase. Therefore, 
this finding needs to be interpreted with caution. For patients treated with IAT only, there was 
no association with favourable or excellent outcome. One series compared IVT in 4 patients 
with endovascular procedures in 6 patients with carotid dissection and tandem occlusion.23 
Patients treated with IVT had worse outcome. However, another series of 18 patients with 
carotid dissection and tandem occlusion (14 patients treated with IVT only, 4 endovascular 
procedures) could not confirm these results.17 Although randomised trials comparing different 
thrombolytic treatment options in CAD are lacking, our data support the use of IVT as 
primary therapeutic strategy in stroke patients, regardless of a suspicion of underlying CAD. 
Since tests to diagnose dissections in the acute phase, such as CTA or MRA, may delay 
start of IVT in the acute phase of stroke, these should preferably be postponed until 
emergency treatment has started. IAT or other endovascular procedures should probably be 
reserved for patients who are not eligible for IVT or who do not recover after IVT.  
 
The most important limitation in this meta-analysis is that no randomized trials were 
available. The pooled estimates are based on retrospective - and mostly uncontrolled - series 
and case reports only. Therefore, the results might be influenced by referral bias. Based on 
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the available data, it seems unlikely that randomized, placebo-controlled trials will be done in 
the future to investigate the safety and efficacy of thrombolysis in patients with ischemic 
stroke secondary to a dissection. Data from completed and ongoing thrombolysis studies and 
larger registries with subgroup analysis based on underlying aetiology are needed for direct 
comparisons between groups.  
 
Another limitation is that we applied a wide treatment window of 24 hours after symptom 
onset, which is beyond the current guidelines of 4.5 hours for IVT. We defined a longer time-
window to allow inclusion of IVT plus IAT studies as well, as long as they were started in the 
acute phase of stroke and not because of deterioration one or more days after onset of 
symptoms. We consider the latter a different group of patients. Median treatment time in our 
study was 165 minutes after symptom onset, indicating that thrombolytic therapy was mostly 
administered in the very acute phase of the stroke, which was the focus of our study.                            
 
In conclusion, thrombolysis seems to be safe in acute ischemic stroke due to CAD. Mortality 
and SICH rate as well as outcome after thrombolysis in this subgroup are comparable with 
the rates in stroke patients from all causes treated with thrombolysis.. In our opinion, 
thrombolytic therapy should therefore not be withheld in patients with CAD related ischemic 
stroke. 
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Table 1. Characteristics of included series (case-reports are not listed). 
 
Study  Design Population No. of patients 
included in meta-
analysis 
Treatment 
 
Engelter et al. 
(2010) 11  
retrospective, multicenter 
multicentre   
55 consecutive patients with stroke due to 
cervical artery dissection treated with IVT 
55 IVT 
Vergouwen et al. 
(2009)26 
retrospective, single centre  8 consecutive patients with stroke due to 
extracranial artery dissection 
6 IVT, IAT 
Putaala et al.  
(2009)24  
retrospective, single centre  48 consecutive patients with stroke aged 16-49 
treated with IVT 
12 IVT 
Huang et al. 
(2009)22 
retrospective, single centre 73 patients with cervicocranial arterial dissection 1 IAT 
Cerrato et al. 
(2008)19 
retrospective, single centre  3 patients with vertebral artery dissection  and 
basilar artery occlusion treated with IAT 
3 IAT.  
Baumgartner et al. 
(2008)17 
retrospective, single centre 18 consecutive patients with internal carotid artery 
dissection and a symptomatic middle cerebral 
artery occlusion 
18 IVT, 
combined 
Lavallée et al. 
(2007)23 
retrospective, single centre 10 patients with tandem internal carotid and 
middle cerebral artery occlusion with internal 
carotid dissection  
5 IVT, 
combined 
Dabitz et al. 
(2007)20  
retrospective, single centre 10 consecutive patients with  acute cerebral 
ischemia associated with proximal carotid  artery 
occlusion 
3 combined 
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Study  Design Population No. of patients 
included in meta-
analysis 
Treatment 
 
Georgiadis et al. 
(2005)27 
retrospective, multicentre  33 consecutive patients with stroke due to 
spontaneous carotid dissection treated with IVT 
33 IVT 
Arnold et al. 
(2002)16 
retrospective, single centre 9 patients with cervical artery dissection treated 
with thrombolysis 
9 IVT, IAT 
Bin Saeed et al. 
(2000)18 
retrospective, single centre 26 patients with vertebral artery dissection 2 IAT 
Derex et al.  
(2000)21 
retrospective, single centre  11 consecutive patients with acute ischemic 
stroke related to internal carotid artery dissection 
treated with IVT 
11 IVT 
Ahmad et al. 
(1999)15 
retrospective, multicentre 18 patients with cervicocerebral artery dissections 2 IAT 
Rudolf et al. 
(1999)25 
retrospective, single centre 15 consecutive patients with internal carotid artery 
occlusion treated with IVT 
6 IVT 
 
IVT = intravenous thrombolysis; IAT = intra-arterial thrombolysis; SAH = subarachnoid hemorrhage; SICH = symptomatic intracerebral 
hemorrhage; AICH = asymptomatic intracerebral hemorrhage; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin 
Score, FIM= Functional Independence Measure; BI = Barthel Index 
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Table 2.  Baseline characteristics of all included CAD patients: individual patient data (IPD) 
Baseline characteristics IPD 
Patients, n 180 
Men, n (%) 57 (32) 
Mean age, years  ± SD 46 ± 11 
Preceding trauma, n  (%) 31 (17) 
Stroke severity 
presenting mean NIHSS ± SD (range) 
median NIHSS (IQR) 
    mild stroke (NIHSS 1-7), n (%) 
   moderate stroke (NIHSS 8-14), n (%) 
   severe stroke (NIHSS ≥ 15), n (%) 
 
15.8 ± 6.9 (1-36) 
16 (11-20) 
21 (15) 
42 (25) 
86 (60) 
Location of dissection  
carotid artery, n (%) 
left carotid artery (%) 
right carotid artery (%) 
bilateral carotid artery (%) 
unknown 
vertebral artery, n (%) 
both, n (%) 
 
131 (73) 
66 (50) 
56 (43) 
4 (3)  
5 (4) 
48 (27) 
1 (1) 
Occlusion before treatment, n (%) 107 (83) 
Intracranial extension, n (%) 16 (10) 
Mean onset to treatment time ± SD (minutes) 
Median (IQR) 
195 ± 123 
165 (125-225) 
Treatment 
IVT only, n (%) 
IAT only, n (%) 
combined, n (%) 
 
121 (68) 
36 (20) 
22 (12) 
Mean duration of follow-up ± SD (months) 3.7 (2.4) 
 
SD = standard deviation; NIHSS = National Institutes of Health Stroke Scale; IVT = 
intravenous thrombolysis; IAT = intra-arterial thrombolysis; IQR = interquartile range
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Table 3a. Safety and outcome in CAD treated with thrombolytic therapy 
Event Proportion Crude estimates Adjusted for heterogeneity 
  % (95% CI) % (95% CI) 
Mortality 14/173 8.1 (4.8 - 13.1) 8.1 (4.9 - 13.2) 
SICH 8/180 4.4 (2.1 - 8.7) 3.1 (1.3 - 7.2) 
Recurrent stroke 8/177 4.5 (2.2 - 8.8) 4.5 (2.3 - 8.7) 
mRS 0-1 63/173 36.4 (29.6 - 43.8) 41.0 (31.4 - 51.4) 
mRS 0-2 103/173 59.5 (52.1 - 66.6) 59.5 (52.1 - 66.6) 
SICH = symptomatic intracerebral hemorrhage; mRS = modified Rankin Score 
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Table 3b. Adverse events and outcome in CAD-patients treated with IVT only 
Event Proportion Crude estimates Adjusted for heterogeneity 
  % (95% CI) % (95% CI) 
Death 8/120 6.7 (2.2 - 11.1) 6.7 (3.4 -13.8) 
SICH 4/121 3.3 (1.0 - 8.5) 3.3 (1.2 - 8.5) 
Recurrent stroke 8/118 6.8 (3.3 - 13.0) 4.5 (3.4 -13.0) 
mRS 0-1 40/120 33.3 (25.5 - 42.2) 41.0 (25.5 - 42.2) 
mRS 0-2 73/120 60.8 (51.9 - 69.1) 59.5 (51.8 - 69.1) 
SICH = symptomatic intracerebral hemorrhage; mRS = modified Rankin Score 
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Table 4. Univariate and multivariate analysis. Odds for excellent and favourable outcome, multivariate analysis is adjusted for stroke severity by 
means of the NIHSS before start of treatment. 
 mRS 0 - 1 mRS 0 - 2 
 Univariate Adjusted for stroke severity Univariate Adjusted  for stroke severity 
Variables OR (95% CI) p OR (95% CI) p OR (95%CI) p OR (95%CI) p 
Gender [female] 0.73 (0.37-1.43) 0.35 0.51 (0.22-1.15) 0.11 1.19 (0.62-2.29) 0.59 0.92 (0.43-1.96) 0.83 
Age 1.01 (0.98-1.04) 0.91 1.00 (0.96-1.04) 0.99 1.00 (0.98-1.03) 0.77 1.00 (0.97-1.03) 0.97 
Preceding trauma 1.79 (0.67-4.77) 0.24 0.43 (0.09-2.03) 0.29 1.70 (0.62-4.66) 0.30 0.82 (0.21-3.20) 0.78 
Dissected artery 
[vertebral artery] 
2.64 (1.24-5.62) 0.01* 3.94 (1.40-11.12) 0.01* 1.11 (0.54-2.28) 0.78 1.92 (0.72-5.11) 
 
0.19 
Onset to treatment time
   continuous 
   < 120 minutes 
   120-180 minutes 
   >180 minutes 
 
1.00 (1.00-1.00) 
reference 
0.75 (0.36-1.57) 
0.63 (0.15-2.58)
 
0.72 
 
0.44 
0.52 
 
1.00 (0.99-1.00) 
 
0.74 (0.32-1.71) 
0.27 (0.03-2.83) 
 
0.42 
 
0.47 
0.27 
 
1.00 (1.00-1.00) 
 
0.68 (0.34-1.34) 
0.32 (0.09-1.18) 
 
0.16 
 
0.26 
0.09 
 
1.00 (0.99-1.00) 
 
0.75 (0.36-1.59) 
0.22 (0.03-1.52) 
 
0.15 
 
0.46 
0.13 
NIHSS 0.88 (0.82-0.93) 0.00* --- --- 0.87 (0.82-0.92) 0.00* --- --- 
Treatment 
   IVT only 
   IAT only 
   combined 
 
reference 
1.49 (0.63-3.55) 
1.93 (0.71-5.28)
 
 
0.36 
0.22 
 
 
2.82 (0.83-9.63) 
1.83 (0.45-7.46) 
 
 
0.10 
0.40 
 
 
0.50 (0.23-1.10) 
2.58 (0.81-8.18) 
 
 
0.09 
0.11 
 
 
0.84 (0.30-2.38) 
3.87 (0.93-16.06) 
 
 
0.75 
0.06 
* p < 0.05. mRS = modified Rankin Score; OR = odds ratio; CI = confidence interval; NIHSS = National Institutes of Health Stroke Scale; IVT = 
intravenous thrombolysis; IAT = intra-arterial thrombolysis
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Table 5. Comparison of the safety of thrombolysis in patients with CAD-related stroke 
(current meta-analysis) compared with patients with stroke from all causes treated with IV 
thrombolysis (data from SITS-MOST). 50 
 
CAD patients Stroke from 
 all causes 
 
All patients  
(n = 180) 
IVT only 
(n = 121) 
SITS-MOST  
(n = 6.483) 
 % (95% CI) % (95% CI) % (95 CI) 
Mortality 8.1 (4.9 - 13.2) 6.7 (3.4 - 12.8) 11.3 (10.5 -12.1) 
SICH  3.1 (1.3 - 7.2) 3.3 (1.2 - 8.5) 1.7 - 7.3* 
 
* Range of SICH rates in SITS-MOST, depending on the definition.   
 
 
 25
Thrombolysis in cervical artery dissection           Zinkstok et al. 
 26
Contributors 
SMZ, MDIV and PJN designed the study, SMZ and PJN did the data search and extracted 
data, SMZ, NvG and PJN did the statistical analysis. SMZ, NvG and PJN designed the 
tables. All authors contributed to the writing of the Article. 
 
Conflicts of interest 
We have no conflicts of interest. 
 
Appendix. Overview of centres providing IPD 
 
Individual patient data of case series were provided by the following centres: 
University Hospital Lausanne (Swiss): 27 patients (22 IVT, 5 combined treatment); University 
Hospital Bern (Swiss): 25 patients (9 IVT, 13 IAT, 3 combined treatment); University Hospital 
Zurich (Swiss): 24 patients (21 IVT, 3 IAT); University Hospital Basel (Swiss): 22 patients (20 
IVT, 2 IAT); University Hospital Helsinki (Finland): 12 patients (12 IVT); University Hospital in 
Mannheim (Germany): 7 patients (7 IVT); Academic Medical Centre University of Amsterdam 
(Holland): 6 patients. Other authors provided additional information regarding clinical status 
20;21;37 or treatment.23  
 
 
 
 
 
